BICYCLE THERAPEUTICS PLC's ticker is BCYC and the CUSIP is 088786108. A total of 87 filers reported holding BICYCLE THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is 3.51 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,350,911 | -27.0% | 266,347 | -7.2% | 0.00% | -100.0% |
Q2 2023 | $7,327,991 | -40.0% | 287,147 | -50.0% | 0.00% | 0.0% |
Q1 2023 | $12,215,234 | +9.3% | 574,294 | +52.1% | 0.00% | 0.0% |
Q4 2022 | $11,178,351 | -27.7% | 377,647 | -43.2% | 0.00% | -50.0% |
Q3 2022 | $15,463,000 | +30.1% | 664,806 | -6.1% | 0.00% | +100.0% |
Q2 2022 | $11,882,000 | -66.3% | 708,080 | -11.9% | 0.00% | -66.7% |
Q1 2022 | $35,268,000 | -60.3% | 803,748 | -45.0% | 0.00% | -57.1% |
Q4 2021 | $88,924,000 | +363.2% | 1,460,882 | +216.5% | 0.01% | +250.0% |
Q3 2021 | $19,199,000 | +199.1% | 461,629 | +118.3% | 0.00% | +100.0% |
Q2 2021 | $6,419,000 | +1.6% | 211,444 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $6,316,000 | +66.4% | 211,444 | 0.0% | 0.00% | – |
Q4 2020 | $3,795,000 | -5.8% | 211,444 | 0.0% | 0.00% | – |
Q3 2020 | $4,028,000 | +22.9% | 211,444 | 0.0% | 0.00% | – |
Q2 2020 | $3,277,000 | – | 211,444 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradigm Biocapital Advisors LP | 3,642,307 | $73,173,948 | 4.96% |
Sio Capital Management, LLC | 796,933 | $16,010,384 | 4.96% |
First Light Asset Management, LLC | 2,070,853 | $41,603,437 | 3.95% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 1,281,820 | $25,751,764 | 3.60% |
Deep Track Capital, LP | 3,490,506 | $70,124,266 | 2.71% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,010,976 | $20,310,508 | 1.10% |
HighVista Strategies LLC | 92,434 | $1,856,999 | 0.86% |
BRAIDWELL LP | 1,289,872 | $25,913,528 | 0.82% |
DAFNA Capital Management LLC | 122,200 | $2,454,998 | 0.76% |
Soleus Capital Management, L.P. | 391,800 | $7,871,262 | 0.73% |